Fullerton Fund Management appoints Ken Goh as Chief Investment Officer
Singapore, Apr 1, 2022 – (ACN Newswire) – Fullerton Fund Management (“Fullerton”) has appointed Ken…
Singapore, Apr 1, 2022 – (ACN Newswire) – Fullerton Fund Management (“Fullerton”) has appointed Ken…
EUROAPI listing on Euronext Paris expected on May 6, 2022 French AMF approved EUROAPI’s listing…
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES,…
TOKYO, Apr 1, 2022 – (JCN Newswire) – Eisai Co., Ltd. announced today that Eisai…
TOKYO, Apr 1, 2022 – (JCN Newswire) – Marubeni Corporation (“Marubeni”), OPExPARK Inc. (“OPExPARK”), Beyond…
HONG KONG, Apr 1, 2022 – (ACN Newswire) – According to South China Morning Post,…
SINGAPORE, Apr 1, 2022 – (ACN Newswire) – 2021 was a huge year for the…
HONG KONG, Apr 1, 2022 – (ACN Newswire) – China Youran Dairy Group Limited (“Youran…
TOKYO, Apr 1, 2022 – (ACN Newswire) – Today, Hidehito Takahashi, President and CEO of…
MYCO-001 Smoking Cessation Clinical Trial Moves Forward Following Conditional IRB Approval Company Advances IP Portfolio…
NEW YORK, March 31, 2022 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (Nasdaq: SLS)…
Toyota City, Japan, Apr 1, 2022 – (JCN Newswire) – TOYOTA GAZOO Racing (TGR) held…
$3.3M in revenue representing 108% Y-Y growth, significant growth in finished product sales Total of…
HONG KONG, Apr 1, 2022 – (ACN Newswire) – InvesTech Holdings Limited (“InvesTech Holdings”, together…
CrowdStrike was the only vendor to demonstrate native and unified Zero Trust and identity protection…
Orphazyme A/S in restructuringCompany announcementNo. 16/2022www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, March 31, 2022 –…
Company Plans to Initiate Phase 3 Study for TMB-001 in Q2 2022 BASKING RIDGE, NJ,…
MONTREAL, March 31, 2022 (GLOBE NEWSWIRE) — Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (Theratechnologies), a…
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES….
SOMERVILLE, Mass., March 31, 2022 (GLOBE NEWSWIRE) — Finch Therapeutics Group, Inc. (“Finch” or “Finch…